Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device. Atlassian cookies and tracking notice, (opens new window)
Welcome to the PHUSE Advance Hub
Teams
, (opens new window)

WORKING GROUPS
Results will update as you type.
  • Working Groups
  • Hot Topics
  • Useful Information
  • Deliverables
  • Working Groups Events
  • Working Groups Report – Q3 2025
  • Working Groups Archive
    • Data Transparency Archive
    • Data Visualisation & Open Source Technology Archive
    • Emerging Trends & Technologies Archive
    • Nonclinical Topics Archive
    • Optimizing the Use of Data Standards Archive
    • Risk Based Quality Management Archive
    • Real World Evidence Archive
      • Best Data Practices for Rare Disease Patient Foundations and Researchers
      • Real-world Evidence (RWE) in Japan
      • Real World Evidence Guidance
    • Therapeutic Areas
    • Good Programming Practice Project Team
    • Working Group Report Archive
    • Safety Analytics Archive
  • Working Groups Events Archive
    You‘re viewing this with anonymous access, so some content might be blocked.
    /
    Best Data Practices for Rare Disease Patient Foundations and Researchers

      Best Data Practices for Rare Disease Patient Foundations and Researchers

      Oct 07, 2024

      Project Scope 

      This project aims to create a guidance about best data practices for patient foundations and for researchers in the form of decision trees, graphics, short printable materials or videos.

      Project Statement 

      The purpose of this Working Group is to create awareness and education about best practices for collecting regulatory quality data from the industry perspective, improving data quality, empowering patients and patient groups with knowledge and information, and building bridges between industry, academics and patient communities.

      Project Impact 

      This project will create greater partnerships between industry, researchers and the patient community. It will also help improve data collection, with the goal of the data being useful to the industry.

      Project LeadsEmail

      Sophia Zilber, Alexion AstraZeneca Rare Disease, Cure Mito Foundation

      sophia.zilber@alexion.com

      Danielle Boyce, Johns Hopkins University

      dboyce3@jhu.edu
      Paul Howard, Amicus Therapeutics

      phoward@amicusrx.com

      Nicola Newton, PHUSE Project Assistant

      nicky@phuse.global 

      CURRENT STATUS Q2 2024

      • Continued sharing the latest resource that was created on assessing registries for regulatory use and discuss direction for next steps. 

      Objectives & Deliverables

      Timelines

      Decide on a strategy to share all three resources, possibly through PHUSE Education webinars Q2 2023
      Published Deliverables
      Ensuring Registry Data Relevance and Reliability for Regulatory Use4 April 2024
      Myths VS Facts About Patient Registries18 May 2023

      Patient Foundations Guide to Starting a Registry

      28 April 2023

      Patient Registry Transparency Checklist For Patient Foundations 

      28 April 2023
      , multiple selections available,
      {"serverDuration": 10, "requestCorrelationId": "4e44ab5800ff41e3ab633f699c019df9"}